Starting in 2025, Medicare Part D plans will have an annual out-of-pocket maximum of $2,000 for prescription drug benefits. Additionally, beneficiaries will have the option to spread their ...

Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall Street analysts ...

President Joe Biden’s Inflation Reduction Act allows Medicare to negotiate costly drug prices with pharmaceutical companies.

The Biden administration is taking a victory lap after federal officials inked deals with drug companies to lower the price for 10 of Medicare’s most popular and costliest drugs. White House officials ...

(Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's ...

Only rigorous analyses assessing the financial implications of several rounds of negotiation will be able to answer the ...

As we have previously reported, the Inflation Reduction Act (IRA) changed the government’s treatment of certain prescription drugs under the ...

How much will Medicare’s price cuts on 10 of the most expensive medications, including diabetes, heart and arthritis drugs, ultimately save older adults at the pharmacy counter? And when will they get ...

The Biden administration has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American older adults.

Axios reports that multiple high-ranking GOP lawmakers said that if Donald Trump wins the election, Republicans might attempt to dismantle the popular price reductions over concerns about ...

Powell: So among the more mind-boggling things on the drugs that are on this top 10 list, one of them costs $13,836 for a ...